Mackenzie Financial’s CTI BioPharma CTIC Stock Holding History
Bought
Maintained
Sold
Other funds holding CTIC
Mackenzie Financial's CTIC Position: Q1 2023 in Review
Mackenzie Financial sold out of CTI BioPharma (CTIC) in Q1 2023, closing a stake of 91,714 shares — an estimated $551K sold.
Mackenzie Financial first reported a position in CTIC in Q4 2022 and held it in 1 quarter. The position peaked at $551K in Q4 2022. 132 funds tracked by Wall St. Rank hold CTIC as of Q1 2023.
- Mackenzie Financial reported no remaining CTI BioPharma position as of Q1 2023 after selling out during the quarter.
- Mackenzie Financial sold 91,714 CTI BioPharma shares in Q1 2023, an estimated $551K.
- Mackenzie Financial first reported a position in CTI BioPharma in Q4 2022 and held it in 1 quarter.
- Mackenzie Financial's CTI BioPharma position peaked at $551K in Q4 2022.
- 132 funds tracked by Wall St. Rank held CTI BioPharma as of Q1 2023.
Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.